| 000 | 01549cam a2200337 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030647.0 | ||
| 008 | 120901s2012 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.08.05.Ph.D.2012.Ya.A | ||
| 100 | 0 | _aYasmin Abdullah Mohamed Aleryani | |
| 245 | 1 | 0 |
_aAnalytical study of some antidepressant drugs / _cYasmin Abdullah Mohamed Aleryani ; Supervised Bahia Abbas Moussa , Ramzia Ismail Elbagary |
| 246 | 1 | 5 | _aدراسة تحليلية لبعض الادوية المضادة للإكتئاب |
| 260 |
_aCairo : _bYasmin Abdullah Mohamed Aleryani , _c2012 |
||
| 300 |
_a425 P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutical Chemistry | ||
| 520 | _aA stability-indication high performance liquid chronatography (HPLC) method of analysis of desvenlafaxine suucinate (DSV) in the presence of its acidic induced- degradation product in pure and pharmaceutical preparation had been developed and validated. The chromatographic conditions comprised of an isocratic reversed | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAcidic degradation product | |
| 653 | 4 | _aDesvenlafaxine succinate | |
| 653 | 4 | _aHPLC | |
| 700 | 0 |
_aBahia Abbas Moussa , _eSupervisor |
|
| 700 | 0 |
_aRamzia Ismail Elbagary , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c39277 _d39277 |
||